|
| 37525323 | Changes in employment status over time in multiple sclerosis following a first episode of central nervous system demyelination, a Markov multistate model study. | | 2024 |
| 37584176 | The Patient-Determined Disease Steps scale is not interchangeable with the Expanded Disease Status Scale in mild to moderate multiple sclerosis. | | 2024 |
| 37541839 | Evaluation of Cell-Specific Epigenetic Age Acceleration in People With Multiple Sclerosis. | | 2023 |
| 36036311 | Validation of the EQ-5D-5L and psychosocial bolt-ons in a large cohort of people living with multiple sclerosis in Australia. | Quality of Life Research | 2023 |
| 36149605 | Using the EQ-5D-5L to investigate quality-of-life impacts of disease-modifying therapy policies for people with multiple sclerosis (MS) in New Zealand. | | 2023 |
| 36448302 | Not all roads lead to the immune system: the genetic basis of multiple sclerosis severity. | Brain | 2023 |
| 37918903 | Exploring the cost-effectiveness of EBV vaccination to prevent multiple sclerosis in an Australian setting. | | 2023 |
| 38085047 | Vitamin D did not reduce multiple sclerosis disease activity after a clinically isolated syndrome. | | 2023 |
| 37884346 | Using qualitative free-text data to investigate the lived experience of the COVID-19 pandemic for a large cohort of Australians with different multiple sclerosis related disability levels. | | 2023 |
| 37628757 | DNA Methylation Signatures of Multiple Sclerosis Occur Independently of Known Genetic Risk and Are Primarily Attributed to B Cells and Monocytes. | Int J Mol Sci | 2023 |
| 37148166 | A pro-inflammatory diet in people with multiple sclerosis is associated with an increased rate of relapse and increased FLAIR lesion volume on MRI in early multiple sclerosis: A prospective cohort study. | | 2023 |
| 36965220 | Healthcare utilisation and perceived healthcare accessibility and quality amongst people living with multiple sclerosis enroled in an online course. | | 2023 |
| 37463930 | The association between disability progression, relapses, and treatment in early relapse onset MS: an observational, multi-centre, longitudinal cohort study. | | 2023 |
| 36894322 | Self-reported behaviour change among multiple sclerosis community members and interested laypeople 6 months following participation in a free online course about multiple sclerosis. | | 2023 |
| 36819664 | The shared genetic landscape of blood cell traits and risk of neurological and psychiatric disorders. | | 2023 |
| 36882223 | Multiple sclerosis mortality in New Zealand: a nationwide prospective study. | | 2023 |
| 37325639 | Interferon beta treatment is a potent and targeted epigenetic modifier in multiple sclerosis. | | 2023 |
| 37062948 | Instruments measuring change in cognitive function in multiple sclerosis: A systematic review. | | 2023 |
| 37442078 | Longitudinal epidemiology of multiple sclerosis in Townsville, Queensland, Australia, 2012-2022. | | 2023 |
| 37186989 | Confidence communicating about multiple sclerosis among enrolees in an online course. | | 2023 |
| 37120966 | Healthcare utilization and satisfaction among enrolees in an online course about multiple sclerosis: A cross-sectional study. | | 2023 |
| 37437240 | Comparative Effectiveness of Autologous Hematopoietic Stem Cell Transplant vs Fingolimod, Natalizumab, and Ocrelizumab in Highly Active Relapsing-Remitting Multiple Sclerosis. | | 2023 |
| 37369086 | The risk of secondary progressive multiple sclerosis is geographically determined but modifiable. | | 2023 |
| 37306550 | Risk of a first clinical diagnosis of central nervous system demyelination in relation to human herpesviruses in the context of Epstein-Barr virus. | | 2023 |
| 36732044 | Genetically determined serum serine level has a novel causal effect on multiple sclerosis risk and predicts disability progression. | | 2023 |
| 37522942 | Estimating the disutility of relapse in relapsing-remitting and secondary progressive multiple sclerosis using the EQ-5D-5L, AQoL-8D, EQ-5D-5L-psychosocial, and SF-6D: implications for health economic evaluation models. | | 2023 |
| 37542923 | Higher dietary quality is prospectively associated with lower MRI FLAIR lesion volume, but not with hazard of relapse, change in disability or black hole volume in people with Multiple Sclerosis. | | 2023 |
| 34807490 | Self-reported behaviour change among multiple sclerosis community members and interested laypeople following participation in a free online course about multiple sclerosis. | Health Promotion Journal of Australia | 2022 |
| 36369345 | Ensemble machine learning identifies genetic loci associated with future worsening of disability in people with multiple sclerosis. | Scientific Reports | 2022 |
| 35902227 | Superior effects of natalizumab versus other DMTs on patient-reported outcomes in people with multiple sclerosis. | Journal of Neurology, Neurosurgery and Psychiatry | 2022 |
| 35652440 | Estimating the impact of work difficulties, work self-efficacy and work psychological safety on MS-related work productivity loss. | Multiple Sclerosis Journal | 2022 |
| 35582938 | Confirmed disability progression as a marker of permanent disability in multiple sclerosis. | European Journal of Neurology | 2022 |
| 35896381 | Poor sleep and multiple sclerosis: associations with symptoms of multiple sclerosis and quality of life. | Journal of Neurology, Neurosurgery and Psychiatry | 2022 |
| 35891671 | Predictors of progression from a first demyelinating event to clinically definite multiple sclerosis. | Brain Communications | 2022 |
| 35577508 | Increasing incidence and prevalence of multiple sclerosis in the Greater Hobart cohort of Tasmania, Australia. | Journal of Neurology, Neurosurgery and Psychiatry | 2022 |
| 36283751 | Protocol for a systematic review and meta-analysis of minimal important differences for generic multiattribute utility instruments. | BMJ Open | 2022 |
| 36007424 | Plexus MRI helps distinguish the immune-mediated neuropathies MADSAM and MMN. | Journal of Neuroimmunology | 2022 |
| 35636273 | Associations between diet quality and depression, anxiety, and fatigue in multiple sclerosis. | Multiple Sclerosis and Related Disorders | 2022 |
| 35943837 | Measurement Properties of the Health Literacy Questionnaire in the Understanding Multiple Sclerosis Massive Open Online Course Cohort: A Rasch Analysis. | Health literacy research and practice | 2022 |
| 35679759 | Generation and characterisation of four multiple sclerosis iPSC lines from a single family. | Stem Cell Research | 2022 |
| 35796711 | What causes multiple sclerosis? Getting closer to the answers. | Medical Journal of Australia | 2022 |
| 35549477 | Long-term trajectories of employment status, workhours and disability support pension status, after a first episode of CNS demyelination. | Multiple Sclerosis Journal | 2022 |
| 35922816 | Safety of low-intensity repetitive transcranial magneTic brAin stimUlation foR people living with mUltiple Sclerosis (TAURUS): study protocol for a randomised controlled trial. | Trials | 2022 |
| 35410900 | Association of Latitude and Exposure to Ultraviolet B Radiation With Severity of Multiple Sclerosis: An International Registry Study. | Neurology | 2022 |
| 36054471 | Prevalence of chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathy in two regions of Australia. | Muscle and Nerve | 2022 |
| 35977441 | Gains in multiple sclerosis knowledge following completion of the Understanding Multiple Sclerosis online course are maintained six months after course completion. | Multiple Sclerosis and Related Disorders | 2022 |
| 35977440 | Reasons for non-completion of a massive open online course about multiple sclerosis: A mixed methods study. | Multiple Sclerosis and Related Disorders | 2022 |
| 35718329 | Beta-adrenergic drugs and risk of Parkinson's disease: A systematic review and meta-analysis. | | 2022 |
| 37435434 | Integrating Genetic Structural Variations and Whole-Genome Sequencing Into Clinical Neurology. | | 2022 |
| 33724638 | Risk of requiring a wheelchair in primary progressive multiple sclerosis: Data from the ORATORIO trial and the MSBase registry. | European Journal of Neurology | 2022 |